News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$BLGO Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage
https://www.accessnewswire.com/newsroom/en/chemicals/independent-evaluation-confirms-breakthrough-performance-of-biolargos-cellinity-battery-t-1040814
WESTMINSTER, CALIFORNIA / ACCESS Newswire / June 18, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that a third-party evaluation has confirmed key advantages for its Cellinity battery technology's use in grid-scale battery energy storage applications.
The evaluation was conducted by U.S. BESS Corporation (www.usbesscorp.com), an expert provider of advanced energy storage solutions for critical infrastructure applications spanning utilities, defense, microgrids, and heavy industry.
U.S. BESS senior technical staff performed an examination of Cellinity's design and assembly protocols, inspection of testing infrastructure, review of data from test results, and an assessment of methodologies used for performance characterization, concluding that the following performance characteristics exclusive of any auxiliary systems are supported by their observations and are reasonably representative of the current Cellinity cell's demonstrated behavior:
Open circuit voltage: > 4.2 V
Operating temperature range: from 120°C to 250°C
Energy density: > 500 Wh/kg (calculated based on active material)
Power density: > 500 mW/cm3 (maximum observed value of 1579 W/kg at 230°C)
Charge capacity: Cell can be charged to 100% of theoretical capacity
Charge/discharge efficiency: ~100%
Energy efficiency: 95% at 230°C; 87% at 120°C
Self-discharge: No measurable self-discharge observed over test durations
Thermal cycling durability: Performance unaffected after repeated cycling
U.S. BESS Corp further concluded that it is reasonable to claim that a) the cell would not experience any thermal runaway, b) materials of construction are commonly available and can be domestically sourced, c) the cell does not contain any rare earth elements, and d) cell components are fully recyclable.
A Market Ready for Disruption
The global demand for grid-scale energy storage is rapidly growing to meet the rising loads driven by artificial intelligence, decarbonization mandates, and accelerated adoption of renewables. In 2024 alone, the U.S. Energy Information Administration (www.eia.gov) reported a 66% increase in U.S. battery energy storage capacity. While lithium-ion batteries currently dominate the market, they present known challenges: fire risks from thermal runaway, efficiency losses over time, and sourcing constraints related to rare and critical minerals.
BioLargo's Cellinity battery technology (www.biolargoenergy.com) overcomes these limitations by leveraging novel materials and architecture to deliver both exceptional thermal performance and operational efficiencywithout relying on rare earth elements.
Validation Supports Commercial Pathway
The U.S. BESS report concludes: "Based on our inspection and the evidence provided, U.S. BESS finds that the Cellinity Cell demonstrates a sufficient performance profile, with strong indications of high thermal stability, efficiency, energy and power density, and material sustainability, to suggest further investment in testing and commercialization. These attributes position this technology as a potential solution for critical gaps in grid-scale energy storage markets."
Randall Moore, Chief Technology Officer at BioLargo Energy Technologies, Inc., commented, "Our work to scale up the cell design, refine manufacturing techniques, and integrate cells into a functional module for commercial scale testing is underway."
CEO, Dennis P. Calvert commented, "We do not know of any long duration energy storage technology that can match Cellinity's technical claims for cost effective performance and safety. This third-party evaluation is an important piece of the puzzle for our business plan to bring Cellinity to the world through manufacturing joint ventures. We have several of these in development with potential partners and look forward to sharing more intel about those soon."
Evidence that BLGO is about to rocket to very big numbers: 
$BLGO Sidoti Events, LLC's Virtual May Micro-Cap Conference
https://www.accessnewswire.com/newsroom/en/banking-and-financial-services/sidoti-events-llcs-virtual-may-micro-cap-conference-1029673
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 21-22, 2025. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
$BLGO BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements
https://www.accessnewswire.com/newsroom/en/chemicals/biolargo-subsidiary-clyra-medical-advances-product-distribution-through-a-series-of-agree-1026956
WESTMINSTER, CA / ACCESS Newswire / May 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and health challenges, today announced that its subsidiary Clyra Medical Technologies, Inc. ("Clyra") has entered into a series of agreements to advance the sales and distribution of its medical products in the U.S. and abroad. Although none of the agreements require minimum product purchases, each agreement has the potential to generate material revenue for Clyra.
Dennis P. Calvert, CEO at BioLargo commented, "These agreements reflect the significant time, energy and resources Clyra has invested to meet client specifications and bring products to market. While no prediction can be made as to when the agreements will result in product sales, or the volume of sales, we believe each could be important as Clyra grows. We look forward to announcing more developments as the products go to market."
$BLGO BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent Technologies
https://www.accessnewswire.com/newsroom/en/chemicals/biolargos-pfas-solution-provides-dramatic-long-term-cost-savings-compared-with-incumbent-1023383
Case studies show the company's innovative capture + destruction two-step approach can offer a scalable, economically feasible solution for PFAS elimination from drinking water, wastewater, and landfill leachate, capable of reducing lifecycle costs by over 80%
WESTMINSTER, CALIFORNIA / ACCESS Newswire / May 5, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced case study data establishing over 80% long-term lifecycle cost savings of its AEC (Aqueous Electrostatic Concentrator) PFAS solution that can capture and destroy PFAS contamination down to non-detect levels in drinking water, wastewater, and landfill leachate.
The over 80% reduction in lifecycle costs (i.e. costs from replacing filtration media or substrate over time, and disposing of waste) comes from a steep reduction of PFAS-laden waste generated by BioLargo's AEC compared to carbon-based treatment systems, as well as lower replacement costs of BioLargo's treatment materials.
Since the inception of federal and state regulations limiting PFAS levels in drinking water (see https://www.epa.gov/sdwa/and-polyfluoroalkyl-substances-pfas), incumbent technologies like granular activated carbon (GAC) and ion exchange resins have been found to carry substantial lifecycle costs driven by the ongoing requirement to replace media and the transportation and disposal of wastes resulting their use into landfills or incinerators. Pending regulations from the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) would increase transportation costs for PFAS-laden waste even further.
BioLargo's AEC turns this paradigm on its head, with less ongoing media replacement, less waste, and ultimately total mineralization of that PFAS-laden waste using a separate electrochemical oxidation process. Learn more about the technology at https://www.biolargoequipment.com/pfas-solutions.
The enclosed figure based on the new case study data compares the lifecycle costs of BioLargo's AEC (in green) and a typical GAC-based system (blue) over a 10-year period. The AEC data were collected from trials with client-provided water and include ongoing costs for replacement membranes and costs to destroy the PFAS-laden waste via electro-oxidation. The GAC costs including ongoing costs for replacement carbon filters based on current pricing but do not include costs associated with transporting or disposing of PFAS-laden waste, or other costs like taxes, fees, and capital costs.
Furthermore, unlike GAC and ion exchange, BioLargo's AEC does not suffer from breakthrough or channeling phenomena that can occur with filtration media based PFAS capture technologies especially with short chain PFAS. In addition to better capturing PFAS chemicals, BioLargo engineers expect this will further reduce maintenance costs due to reduced frequency of media change-outs.
"Waste equals cost," said Tonya Chandler, President of BioLargo Equipment Solutions & Technologies. "We built the AEC specifically to capture PFAS efficiently onto small volumes of substrate. That means lower disposal costs, more affordable and less frequent maintenance, lower regulatory liability, and better, budget-friendly economics for utilities and municipalities trying to protect public health."
In an era when the public is demanding safe drinking water and the federal government is stepping up enforcement on PFAS under CERCLA, BioLargo's American-made technology offers a realistic path to addressing tough PFAS drinking water standards with less capital and operational costs than GAC and ion exchange technologies.
$BLGO BioLargo Provides 2024 Review and 2025 Outlook
https://www.accesswire.com/968767/biolargo-provides-2024-review-and-2025-outlook
Continued Strong Revenue Growth; Zero Share Dilution in 2nd Half of 2024
WESTMINSTER, CA / ACCESSWIRE / January 15, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, is pleased to provide a recap of its successful 2024, and provide a corporate and business outlook for 2025.
"Thanks to the support of our shareholders, business partners, operating teams, and board, BioLargo had a widely successful 2024 spanning our business segments, financials, and stock performance. This past year was transformative for our company and was a testament to our evolution as a cleantech innovator and solutions provider. Our mission to create new cleantech technologies to solve tough problems advanced across all our operating segments," stated Dennis P. Calvert, President and CEO of BioLargo, Inc.
"Pooph, our consumer pet odor product line, is a great example of our core business model to invent a technology, prove it out, then partner with an expert that has the resources to properly monetize resulting products," continued Mr. Calvert. "Here, we partnered with award-winning consumer product experts to capitalize on our odor control technology. We receive a manufacturer's margin, royalty on sales, and 20% participation in any eventual sale of the brand. Pooph proved to be a significant contributor of revenue in 2024, having ramped to eight unique products, with more than fifteen SKUs available at retailers such as Amazon, Walmart, Target, The Home Depot, Petsmart, Chewy, PetCo and more."
Mr. Calvert continued, "Pooph was not our only success in 2024, as great strides were also made in our medical, equipment and energy divisions. In medical, our subsidiary Clyra Medical focused its efforts on preparation of its Bioclynse wound irrigation solution for launch for surgical applications, spending countless hours and more than $2 million readying the product for at-scale manufacturing at an FDA-compliant manufacturing partner."
"Our battery technology subsidiary completed its pilot manufacturing facility and successfully produced and tested prototype cells revalidating key data that came with the initial acquisition," stated Mr. Calvert. "Our liquid-sodium battery doesn't have the drawbacks of lithium cells - no runaway fires, no toxic or hard-to-source chemicals or minerals - and provides a better option for energy storage, empowering grid stability and storage of renewable energy. It's safer, more sustainable, more durable and more cost-efficient than other batteries. In 2025, we are working hard to scale up cells and battery packs, complete third-party validation testing, and secure manufacturing licensing partnerships around the world."
"Our innovative water treatment technologies made progress in 2024, securing the first commercial PFAS-treatment project, a project which we expect to be installed and running in early 2025. Our team at BioLargo Equipment Solutions & Technologies is highly encouraged by the pending completion of the first installation, and believes that project will springboard additional customers, which we hope will solidify our technology as a leader in economical, low-waste treatment of water contaminated with these ‘forever chemicals'", said Calvert.
He concluded by saying, "By maintaining a strong focus on financial responsibility and operational efficiency, we aim to maximize shareholder value while advancing our mission to drive innovation and expand our commercialization and product portfolio in 2025 and beyond."
2024 Corporate and Financial Review Highlights
Stock performance appreciation from $0.17 at the end of 2023 to a high of $0.45 in 2024, and currently at $0.30
Cash balance of $3.9 million at the end of the third quarter 2024; from $3.5 million at December 31, 2023
Shareholders' equity reached $6.0 million at the end of the third quarter 2024; from $4.2 million at December 31, 2023
Uplist from the OTCQB to the "OTCQX Best Market", the OTC Markets highest market level for established, investor-focused U.S. and international companies that meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and remain current in their disclosure
Less reliance on investor capital in the second half of 2024 due to increases in gross profits from operations, with no sales of common stock in the 2nd half of 2024
2025 Corporate Outlook
Having expanded the company's strong foundation and achieved impressive revenue growth in 2024, BioLargo is now looking ahead to broaden the commercial traction of its operating segments and products even further in 2025. Each of BioLargo's subsidiaries have potential to transform their respective markets and improve lives around the world. Based on the company's track record of growth and adoption in new business segments underway, management believes 2025 could shape up to be another record year.
BioLargo management has identified its key goals for the coming year:
Uplist to a national stock exchange such as NASDAQ or the NYSE
Grow top line revenues and continue historical revenue growth performance
Complete the years-long effort to launch the Bioclynse wound irrigation solution for use during surgery through an industry-leading distribution partner
For PFAS, complete system installation in New Jersey, collect data from its operations, and sell more treatment systems
For the battery company, complete development of the commercial-sized Cellinity battery cell and packs, validate performance claims through third-party experts, and secure partners for its franchise business model to build factories around the world
Support the expanding growth of the Pooph pet odor control product line
2024 in Review Highlights
Here the company has provided headlines and links to some of the key press releases from 2024:
BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)
https://www.biolargo.com/post/biolargo-inc-ceo-dennis-p-calvert-appointed-to-u-s-department-of-commerce-environmental-technolo
BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
https://www.biolargo.com/post/biolargo-validates-key-performance-metrics-of-its-cellinity-battery-energy-storage-technology
BioLargo Hosts Ribbon-Cutting Event for Battery Pilot Manufacturing Facility
https://www.biolargo.com/post/biolargo-to-host-ribbon-cutting-event-for-battery-pilot-manufacturing-facility
Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer
https://www.biolargo.com/post/clyra-medical-technologies-a-subsidiary-of-biolargo-appoints-dr-steven-j-kavros-as-chief-medical
BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
https://biolargo.blogspot.com/2024/06/biolargo-engineering-increases-ongoing.html
BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
https://biolargo.blogspot.com/2024/06/biolargo-subsidiary-clyra-medical.html
BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
https://biolargo.blogspot.com/2024/06/biolargo-manufactures-first-cellinity.html
BioLargo PFAS Removal Technology Meets New US Drinking Water Standards
https://biolargo.blogspot.com/2024/04/biolargo-pfas-removal-technology-meets.html
BioLargo Adds Larry Dick, Prominent Water Industry Veteran, to Board of Its Water Equipment Subsidiary
https://biolargo.blogspot.com/2024/02/biolargo-adds-larry-dick-prominent.html
BioLargo Recruits Sally Gutierrez, Former EPA Senior Advisor, for the Board of its Water Equipment and PFAS Solutions Company
https://biolargo.blogspot.com/2024/02/biolargo-recruits-sally-gutierrez.html
Jeffrey Kightlinger, Recognized Water Industry Leader, Joins Board of BioLargo's Water Equipment and PFAS Solutions Company
https://biolargo.blogspot.com/2024/02/jeffrey-kightlinger-recognized-water.html
BioLargo Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
https://biolargo.blogspot.com/2024/01/biolargo-launches-water-equipment.html
$BLGO BioLargo, Inc. CEO Dennis P. Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee (ETTAC)
https://www.accesswire.com/953750/biolargo-inc-ceo-dennis-p-calvert-appointed-to-us-department-of-commerce-environmental-technologies-trade-advisory-committee-ettac
WESTMINSTER, CA / ACCESSWIRE / December 12, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its President and CEO Dennis P. Calvert has been appointed by U.S. Secretary of Commerce Gina Raimondo to serve on the Environmental Technologies Trade Advisory Committee (ETTAC).
The ETTAC is a U.S. Department of Commerce committee that serves as an advisory body to the Environmental Trade Working Group (ETWG) of the Trade Promotion Coordinating Committee (TPCC), reporting through the Secretary of Commerce in her capacity as Chair of the TPCC, on trade policies and programs affecting the U.S. environmental technology industry, including programs to promote export of environmental technologies and services. ETTAC members are selected from industry-leading companies across sectors including water and wastewater treatment, air quality control, and solid waste management and recycling. Learn more at https://www.trade.gov/ettac.
On December 11, 2024, the Department of Commerce issued a press release announcing the ETTAC committee appointments for the 2024-2026 term: https://www.commerce.gov/news/press-releases/2024/12/us-secretary-commerce-appoints-new-advisors-environmental-technologies
"The U.S. environmental technologies sector represents $432 billion in revenue and employs 1.8 million American workers - making it a vital industry for driving innovation and positioning the United States as a global leader in environmental technologies," said Secretary Raimondo. "I look forward to receiving the committee's recommendations on approaches for how the Department can continue supporting the competitiveness of American environmental technologies."
Mr. Calvert, who will serve a two-year term on the ETTAC, commented, "I am honored to serve the Secretary of Commerce and advocate for programs that foster the expanded use of innovative technologies to safeguard the environment and human health."
He continued, "American innovators lead the world in the development of newer and better environmental technologies to address challenges such as sustainable water treatment targeting emerging contaminants like per- and polyfluoroalkyl substances (PFAS). Now is the time to promote the export of these technologies around the world to address these global issues."
Learn more about BioLargo's environmental technologies at www.biolargo.com.
$BLGO BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time
https://www.accesswire.com/941977/biolargo-q3-2024-earnings-results-webcast-and-conference-call-on-thursday-november-14-2024-430-pm-eastern-time
WESTMINSTER, CA / ACCESSWIRE / November 13, 2024 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday, November 14, 2024 at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months and nine months ending September 30, 2024, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/51659
Teleconference Domestic: 888-999-6281
Teleconference International: +1-848-280-6550
Participant Access Code: BioLargo Inc.
To watch or listen to a replay of the webcast or teleconference:
Webcast Replay Expiration: Friday, February 14, 2025
Teleconference Replay Expiration: Thursday, November 28th, 2024
Teleconference Replay Domestic: 877-481-4010
Teleconference Replay International: 919-882-2331
Replay Passcode: 51659
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
$BLGO BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology
https://www.accesswire.com/930981/biolargo-validates-key-performance-metrics-of-its-cellinity-battery-energy-storage-technology
WESTMINSTER, CA / ACCESSWIRE / October 14, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its subsidiary BioLargo Energy Technologies, Inc. completed preliminary internal testing of its prototype battery cells confirming many of the technology's exceptional performance claims that make it an attractive battery technology for long duration energy storage.
The tests, done to verify the battery's performance claims made by its original inventors, confirmed the stability of the chemistry of the battery cell and the reliability of the component construction as a sealed, non-venting cell design with no self-discharging. The tests also helped verify the battery's ability to quickly charge and discharge at a high voltage.
Cellinity™ is BioLargo's next-generation battery platform designed to provide a better alternative to lithium-ion technology for applications including grid-scale storage, renewable energy storage, charging stations for electric vehicles, and a variety of other commercial and industrial applications. Cellinity is safer, more sustainable, longer lasting, and more energy-dense than lithium-ion batteries, traits that make it ideal for large-format long-duration energy storage applications. Learn more about Cellinity at www.BioLargoEnergy.com.
In addition to these internal tests, the company is also organizing third-party validation testing to be done on the more complex aspects of Cellinity's electrochemical performance with at least two acclaimed testing facilities.
Dennis P. Calvert, President and CEO of BioLargo, commented "With these results in hand, our engineers are now advancing the next steps in Cellinity's development: design and production of the larger format 'Spartan' Cellinity cells, and design and production of battery modules containing those cells. Stay tuned - we're very excited about the future of this important battery technology, and we think you should be too."
He continued, "According to a recently published article in The Economist titled 'Clean energy's next trillion-dollar business', global energy storage experts have predicted the global supply of battery energy storage will need to increase from today's 200 gigawatts to more than a terawatt by 2030 and more than five terawatts by 2050, fueling a market projected to be worth between $200 billion and $700 billion by 2030 and between $1 and $3 trillion by 2040. These projections underscore the critical role of batteries in the global energy transition and the massive global investment in battery innovation required to meet those targets. Because of its unique differentiators in safety, energy density, and lifespan, Cellinity is especially well-suited to assist in the global energy transition, and we intend to capitalize on that."
$BLGO BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
https://www.accesswire.com/879444/biolargo-engineering-increases-ongoing-revenue-with-another-air-force-contract
USAF work now amounts to over $100,000 in revenue per month.
WESTMINSTER, CA / ACCESSWIRE / June 20, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its engineering subsidiary has been awarded a subcontract to provide air quality services to two Arizona U.S. Air Force bases for up to four years, with expected annual revenue of approximately $812,000.
The news comes on the heels of a similar recently announced contract award to serve three Air Force bases in New Mexico, which has a potential annual average revenue of $650,000. BioLargo's work at the Arizona bases consists primarily of the air quality regulatory compliance portion of a Fence-to-Fence (F2F) support contract through prime contractor HLTLI Joint Venture, LLC, a joint venture between HL Environmental Services and TLI Solutions.
The four-year prime contract secures pricing for F2F services over the term of the contract but does not guarantee continuation of the contract over that duration. In the past, BioLargo's engineers have continued providing services through the duration of the prime contract. In total, BioLargo Engineering's work at Air Force bases now amounts to over $100,000 of revenue per month.
BioLargo Engineering, Science & Technologies President Randall Moore commented, "We are pleased and honored to continue providing vital engineering services to the United States Air Force and supporting their active mission and environmental compliance needs. These new contracts will provide for over $100,000 a month of ongoing fixed revenues while we continue to expand our abilities to support new opportunities."
$BLGO BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
https://www.accesswire.com/876410/biolargo-subsidiary-clyra-medical-selects-keystone-industries-to-support-manufacturing-of-its-medical-products
WESTMINSTER, CA / ACCESSWIRE / June 12, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, announced that its subsidiary Clyra Medical Technologies, Inc. ("Clyra") has selected Keystone Industries, a global manufacturer of medical, dental and cosmetic products with distribution partners in more than 70 countries, to support manufacturing of its medical products. The relationship focuses on the build-out of scaled manufacturing capacity for Clyra's FDA 510(k) cleared Bioclynse surgical wound irrigation solution. Clyra and Keystone have been and continue to make significant investments to support the launch of Bioclynse.
Bioclynse is Clyra's FDA 510(k) cleared, safe, highly effective, broad spectrum wound irrigation solution with enormous potential to improve patient outcomes in applications like orthopaedic surgery and dentistry. Advantages of Bioclynse include:
Non-cytotoxic, non-sensitizing, no damage to tissue
No rinse-out required
Non-staining
Sustained multi-day efficacy
Effective against biofilms
Cary Robinson, President and CEO of Keystone Industries, said, "We are excited to support Clyra Medical Technologies to bring Bioclynse to the market. Keystone has a century of experience in developing and manufacturing medical device, OTC and pharmaceutical products. We have committed a significant investment in our infrastructure to support the manufacturing of innovative products like Clyra's Bioclynse and can readily provide the needed support to scale up production rapidly."
Steve Harrison, President of Clyra Medical Technologies, commented, "We are continuing to work hard and spend money to support the scaled roll-out of the Bioclynse surgical wound irrigation solution. Finding a manufacturing partner willing to invest significant money in new equipment and dedicated space was critical to these efforts. We look forward to a long and mutually prosperous relationship with Keystone."
Looking Great! $BLGO
Nice volume into the close and #HOD $BLGO
$BLGO EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC
https://www.accesswire.com/855647/epa-adds-pfas-to-cercla-superfund-law-favoring-low-waste-systems-like-biolargos-aec
BioLargo’s PFAS treatment technology generates a fraction of the waste compared to carbon filtration
WESTMINSTER, CA / ACCESSWIRE / April 23, 2024 / BioLargo, Inc. (OTCQB:BLGO), a company that creates and commercializes sustainable technologies to solve tough environmental and cleantech challenges, today provided commentary on the importance of a final decision by the U.S. Environmental Protection Agency (EPA) to regulate two per- and polyfluoroalkyl substance (PFAS) chemicals as "hazardous substances" under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA), also known as the Superfund law. BioLargo's PFAS treatment solution, the Aqueous Electrostatic Concentrator, generates a small fraction of the volume of PFAS-laden waste that carbon filtration systems generate, thus reducing operational costs of waste handling, transport, and disposal.
In the EPA press release, EPA Administrator Michael S. Regan stated, "Designating these chemicals under our Superfund authority will allow EPA to address more contaminated sites, take earlier action, and expedite cleanups, all while ensuring polluters pay for the costs to clean up pollution threatening the health of communities." These new regulations come on the heels of the EPA's announcement two weeks ago setting PFAS drinking water limits as low as four parts per trillion.
This new EPA action also means that these PFAS chemicals will be listed as "hazardous materials" under the Hazardous Materials Transportation Act, which will require materials containing these chemicals to be transported using special protocols.
Tonya Chandler, President of BioLargo Equipment Solutions & Technologies, Inc., which markets BioLargo's PFAS treatment systems, commented, "We believe these and other upcoming regulations create a price advantage for our AEC system over competing sorbent technologies such as carbon filtration. With less waste generated, we can also offer clients waste handling all the way through to full destruction at our facility."
These finalized CERCLA regulations are the most recent step by the EPA to limit exposure of Americans to PFAS. In addition to the recently announced federal drinking water standards for six PFAS chemicals, the agency also committed $9 billion in funding to help communities and water providers address contamination by PFAS and other emerging contaminants. This funding will assist communities and water providers to acquire PFAS monitoring and treatment systems to comply with new regulations.
Dennis P. Calvert, President and CEO of BioLargo, commented, "We're pleased to see the U.S. government taking PFAS seriously and dedicating the billions of dollars in funding needed to protect municipal water supplies across the country."
hey got a first contract for PFAS
Look at it on: cleantech innovator Biolargo first there you can read: First PFAS REMOVAL CLIENT8
yes it is doubfulll. But going from the third semester , we receive 7.9 million and that is 107% higher than the semester before; i am in for the end of 2023 we go to 10million and perhaps more. I am waiting for the Aec when it receive the pro they need.
|
Followers
|
46
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
903
|
|
Created
|
05/07/07
|
Type
|
Free
|
| Moderators | |||
AI
